These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6811162)

  • 1. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1982 Aug; 123(3):241-50. PubMed ID: 6811162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1981 Apr; 112(1):55-66. PubMed ID: 6786803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the Sanfilippo type B syndrome using radiolabelled oligosaccharides as substrates for the estimation of alpha-N-acetylglucosaminidase.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1982 Mar; 120(1):77-86. PubMed ID: 6802523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphamidase activity in leucocytes, cultured skin fibroblasts and amniotic cells: diagnosis of the Sanfilippo A syndrome with the use of radiolabelled disaccharide substrate.
    Hopwood JJ; Elliott H
    Clin Sci (Lond); 1981 Dec; 61(6):729-35. PubMed ID: 6794973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanfilippo D syndrome: estimation of N-acetylglucosamine-6-sulfatase activity with a radiolabeled monosulfated disaccharide substrate.
    Freeman C; Hopwood JJ
    Anal Biochem; 1989 Feb; 176(2):244-8. PubMed ID: 2500866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligosaccharide substrates for heparin sulfamidase.
    Thompson JN; Rodén L; Reynertson R
    Anal Biochem; 1986 Feb; 152(2):412-22. PubMed ID: 3083713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the Sanfilippo D syndrome by the use of a radiolabeled monosaccharide sulfate as the substrate for the estimation of N-acetylglucosamine-6-sulfate sulfatase.
    Elliott H; Hopwood JJ
    Anal Biochem; 1984 Apr; 138(1):205-9. PubMed ID: 6428270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1981 Apr; 112(1):67-75. PubMed ID: 6786804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
    Hopwood JJ; Muller VJ
    Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depolymerisation of heparin to produce radio-labelled substrates for sulfamidase, 2-acetamido-2-deoxy-alpha-D-glucosidase, acetyl-CoA:2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase, and 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase.
    Hopwood JJ; Elliott H
    Carbohydr Res; 1981 May; 91(2):165-90. PubMed ID: 7018684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
    Muller VJ; Hopwood JJ
    Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):605-14. PubMed ID: 1546976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3H-labelled trisaccharide from heparin as substrate for acetyl-CoA: 2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase.
    Klein U; von Figura K
    Carbohydr Res; 1980 Jan; 78(2):249-56. PubMed ID: 6766355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanfilippo A syndrome: sulfamidase deficiency in cultured skin fibroblasts and liver.
    Matalon R; Dorfman A
    J Clin Invest; 1974 Oct; 54(4):907-12. PubMed ID: 4214836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
    Perkins KJ; Muller V; Weber B; Hopwood JJ
    Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
    Hopwood JJ
    Carbohydr Res; 1979 Mar; 69():203-16. PubMed ID: 106967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA).
    Karpova EA; Voznyi YaV ; Keulemans JL; Hoogeveen AT; Winchester B; Tsvetkova IV; van Diggelen OP
    J Inherit Metab Dis; 1996; 19(3):278-85. PubMed ID: 8803769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5185-9. PubMed ID: 33384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.
    Hopwood JJ; Elliott H; Muller VJ; Saccone GT
    Biochem J; 1986 Mar; 234(3):507-14. PubMed ID: 3087346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of phenotypic severity in mucopolysaccharidosis type IIIA.
    Knottnerus SJG; Nijmeijer SCM; IJlst L; Te Brinke H; van Vlies N; Wijburg FA
    Ann Neurol; 2017 Nov; 82(5):686-696. PubMed ID: 29023963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.